Journal article
ISTH DIC subcommittee communication on anticoagulation in COVID‐19
Abstract
Hypercoagulability is an increasingly recognized complication of SARS-CoV-2 infection. As such, anticoagulation has become part and parcel of comprehensive COVID-19 management. However, several uncertainties exist in this area, including the appropriate type and dose of heparin. In addition, special patient populations, including those with high body mass index and renal impairment, require special consideration. Although the current evidence …
Authors
Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
Journal
Journal of Thrombosis and Haemostasis, Vol. 18, No. 9, pp. 2138–2144
Publisher
Elsevier
Publication Date
9 2020
DOI
10.1111/jth.15004
ISSN
1538-7933